Results 161 to 170 of about 53,162 (283)

Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aims Conflicting data on hepatocellular carcinoma (HCC) survival in people with HIV (PWH) may depend on tumour aggressiveness and access to curative treatments. We compared outcomes of two HCC cohorts according to HIV status.
Massimo Iavarone, Eleonora Alimenti, Massimo Puoti, Hamid Hasson, Bianca Monti, Sherrie Bhoori, Francesco Peracchi, Alessia Siribelli, Marco Fava, Mariangela Bruccoleri, Marco Merli, Giulia Morsica, Annalisa De Silvestri, Paolo Bonfanti, Antonella Castagna, Alessandro Soria, Pietro Lampertico   +16 more
wiley   +1 more source

Soluble Programmed Cell Death-1: A Potential Predictor of HBsAg Loss in Pediatric Patients with Chronic Hepatitis B Undergoing Peginterferon Therapy. [PDF]

Immunotargets Ther
Yang G, Gan Y, Xia M, Fu Q, Zhang M, Luo K, Wang Z.   +6 more
europepmc   +1 more source

HBsAg and Anti-HCV Prevalence among Pregnant Women Accessing Antenatal Care in a Tertiary Healthcare Facility in Central Nigeria

, 2018
Victor B. Oti, Pennap Gr, Ngari Hr
openalex   +1 more source

STUDY OF rs1059513 STAT6 POLYMORPHISM IN HBsAg(+) HEPATOCELLULAR CARCINOMA PATIENTS

, 2023
Quang Nhựt Lê, Quang Huy Dương, Xuân Kiên Nguyễn   +2 more
openalex   +2 more sources

Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD: A Cross‐Sectional Study From the NHANES Database

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Objective The role of circulating fatty acids (FA) as well as the association between their composition and metabolic dysfunction‐associated steatotic liver disease (MASLD) is not known. Here, we evaluate the association between specific FA subtypes and both MASLD and liver fibrosis in a general population setting.
Stefano Ciardullo, Michela Vergani, Mariangela Rizzo, Alice Oltolini, Alessia Bongo, Emanuele Muraca, Gianluca Perseghin   +6 more
wiley   +1 more source

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. [PDF]

Gut
Wu X, Quan D, Li W, Wisskirchen K, Wu W, Zhou Y, Liu YP, Wan X, Wang X, Zhang X, Yang L, Zheng M, Zhang K, Protzer U, Du S, Qu X.   +15 more
europepmc   +1 more source

Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs

, 2017
Yan Qiao, Shanshan Lu, Zhihui Xu, Xiaodong Li, Kai Zhang, Yan Liu, Li Zhao, Rongjuan Chen, Lanlan Si, Shumei Lin, Dongping Xu, Jin Li   +11 more
openalex   +2 more sources

Machine Learning Prediction of 90‐Day Mortality in HBV‐Related ACLF Using Olink‐Derived Inflammatory Protein Signatures

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background Hepatitis B virus‐induced acute‐on‐chronic liver failure (HBV‐ACLF) has extremely high mortality rates and is closely linked to inflammatory responses. Early interventions in high‐risk patients can significantly improve survival rates.
Yi Zhang, Lina Sun, Huimin Liu, Ke Shi, Yu Lu, Ying Feng, Xianbo Wang   +6 more
wiley   +1 more source

Prevalence and Implications of Occult Hepatitis B Virus Infection Among Blood Donors in Saudi Arabia: A Systematic Review and Meta-Analysis. [PDF]

Diagnostics (Basel)
Tounsi WA.
europepmc   +1 more source

HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma

, 2018
Xue Jing, Zibin Tian, Pujun Gao, Huashi Xiao, Xiaolong Qi, Yanan Yu, Xueli Ding, Lin Yang, Liang Zong   +8 more
openalex   +2 more sources